Mesa Laboratories (NASDAQ:MLAB - Get Free Report) issued its earnings results on Wednesday. The medical instruments supplier reported $2.76 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.09 by $0.67. The business had revenue of $63.72 million during the quarter, compared to analysts' expectations of $65.21 million. Mesa Laboratories had a return on equity of 22.02% and a net margin of 1.51%.